aspartylglutamate has been researched along with glutamic acid in 1 studies
Studies (aspartylglutamate) | Trials (aspartylglutamate) | Recent Studies (post-2010) (aspartylglutamate) | Studies (glutamic acid) | Trials (glutamic acid) | Recent Studies (post-2010) (glutamic acid) |
---|---|---|---|---|---|
15 | 0 | 6 | 41,757 | 452 | 12,876 |
Protein | Taxonomy | aspartylglutamate (IC50) | glutamic acid (IC50) |
---|---|---|---|
Chain A, GLUTAMATE RECEPTOR SUBUNIT 2 | Rattus norvegicus (Norway rat) | 0.821 | |
Chain A, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
Chain B, Glutamate Receptor Subunit 2 | Rattus norvegicus (Norway rat) | 0.821 | |
Metabotropic glutamate receptor 8 | Homo sapiens (human) | 0.0057 | |
Glutamate receptor ionotropic, NMDA 2D | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 3B | Homo sapiens (human) | 0.07 | |
Glutamate receptor 1 | Rattus norvegicus (Norway rat) | 0.5885 | |
Glutamate receptor 2 | Rattus norvegicus (Norway rat) | 0.5885 | |
Glutamate receptor 3 | Rattus norvegicus (Norway rat) | 0.5885 | |
Glutamate receptor 4 | Rattus norvegicus (Norway rat) | 0.5885 | |
Glutamate receptor ionotropic, kainate 1 | Rattus norvegicus (Norway rat) | 0.38 | |
Glutamate receptor ionotropic, NMDA 1 | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, kainate 2 | Rattus norvegicus (Norway rat) | 0.38 | |
Glutamate receptor 1 | Homo sapiens (human) | 0.613 | |
Glutamate receptor 2 | Homo sapiens (human) | 0.613 | |
Glutamate receptor 3 | Homo sapiens (human) | 0.613 | |
Glutamate receptor ionotropic, kainate 3 | Rattus norvegicus (Norway rat) | 0.38 | |
Excitatory amino acid transporter 1 | Homo sapiens (human) | 207 | |
Glutamate receptor 4 | Homo sapiens (human) | 0.613 | |
Glutamate receptor ionotropic, NMDA 2A | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, NMDA 2B | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, NMDA 2C | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, kainate 4 | Rattus norvegicus (Norway rat) | 0.38 | |
Glutamate receptor ionotropic, NMDA 1 | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 2A | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 2B | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 2C | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 2D | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, kainate 5 | Rattus norvegicus (Norway rat) | 0.38 | |
Glutamate receptor ionotropic, NMDA 3A | Homo sapiens (human) | 0.07 | |
Glutamate receptor ionotropic, NMDA 3B | Rattus norvegicus (Norway rat) | 0.1533 | |
Glutamate receptor ionotropic, NMDA 3A | Rattus norvegicus (Norway rat) | 0.1533 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belokrylov, GA; Sorochinskaya, EI | 1 |
1 other study(ies) available for aspartylglutamate and glutamic acid
Article | Year |
---|---|
Immuno-, phagocytosis-modulating and antitoxic properties of dipeptides are defined by the activity of their constituent amino acids.
Topics: Amino Acids; Animals; Antidotes; Aspartic Acid; Benzene; Dipeptides; Glutamic Acid; Granulocytes; Immune System; Male; Methionine; Mice; Mice, Inbred CBA; Phagocytosis; Rabbits; T-Lymphocytes; Tryptophan | 1999 |